Please check out the detailed report from Dr. Soe Thiha Maung, who participated in APASL Early Career Fellowship from July to October,2025. We hope this report will encourage young doctors to apply for ASPASL Fellowship Program 2026, which will offer the winners opportunities to study at their preferred institution with financial support of USD10,000 !! https://www.apasl.info/wp-apasl/wp-content/uploads/2025/11/Final-Report-for-APASL-Fellowship-2025-Dr.-Soe-Thiha-Maung.pdf

Registration has started for APASL Oncology 2026 Tokyo !! We are delighted to announce to you that we have launched the registration for APASL Oncology 2026 Tokyo !! We are looking forward to welcoming a lot of attendees !! https://www.apasl-oncology2026tokyo.org/reg.html

Conference date of APASL STC 2025 Qingdao has been changed to November 28-30, 2025 !! We are waiting for your involvement !!

Please check out our Guideline page from the following URL !! Guidelines

The B-Together study explores the potential of bepirovirsen in modulating immune responses to enhance the clearance of HBV-infected hepatocytes. This research highlights a promising step toward achieving a functional cure for chronic hepatitis B through targeted immunomodulation. Read the full article: https://link.springer.com/article/10.1007/s12072-025-10917-0 #HepatitisB#HBVResearch#Immunotherapy#Hepatology#LiverDisease#Bepirovirsen#HepatologyInternational#ViralHepatitis#ClinicalResearch#HealthcareProfessionals

Emerging data from the Paracelsus 10,000 Study reveal a significant association between depression and metabolic dysfunction-associated steatotic liver disease (MASLD), underscoring the complex interplay between mental health and metabolic liver disease. This cross-sectional analysis emphasizes the importance of integrated care approaches in managing patients with MASLD and related comorbidities. Read the full article: https://link.springer.com/article/10.1007/s12072-025-10922-3 #MASLD#LiverHealth#Depression#MentalHealth#Hepatology#MetabolicDisease#HepatologyInternational#LiverResearch#PublicHealth#HealthcareProfessionals

Emerging data from the Paracelsus 10,000 Study reveal a significant association between depression and metabolic dysfunction-associated steatotic liver disease (MASLD), underscoring the complex interplay between mental health and metabolic liver disease. This cross-sectional analysis emphasizes the importance of integrated care approaches in managing patients with MASLD and related comorbidities. Read the full article: https://link.springer.com/article/10.1007/s12072-025-10922-3 #MASLD#LiverHealth#Depression#MentalHealth#Hepatology#MetabolicDisease#HepatologyInternational#LiverResearch#PublicHealth#HealthcareProfessionals

Understanding the stage-specific impact of portal hypertension is crucial in optimizing surgical outcomes for hepatocellular carcinoma (HCC). This study provides valuable insights into how portal hypertension influences prognosis and postoperative outcomes following liver resection, emphasizing the importance of individualized treatment strategies. Read the full article here: https://link.springer.com/article/10.1007/s12072-025-10879-3 #Hepatology#LiverSurgery#HCC#PortalHypertension#LiverResection#HepatologyInternational#LiverCancer#ClinicalResearch#Oncology#Hepatobiliary

Please check out the Scientific Program of APASL STC 2025 Yangon scheduled on December 13-14 !! We are so thrilled to welcome you in the beautiful city of Yangon !! Scientific Program – APASL – SINGLE TOPIC CONFERENCE 2025, YANGON

APASL STC 2025 Pakistan will be held on December 5-7 !! Please check out its details from the following URL !!

APASL STC 2025 Qingdao scheduled on November 1-2 is just around the corner !! We look forward to your active involvement !!

Discover new insights into the immune landscape of chronic hepatitis B through this study on B-cell subset heterogeneity in the liver. The findings enhance understanding of immune regulation and its implications for disease progression and therapeutic strategies in HBV infection. Read the full article: https://link.springer.com/article/10.1007/s12072-025-10930-3 #HepatitisB#LiverImmunology#HepatologyResearch#ChronicHBV#BCells#HepatologyInternational#LiverScience#MedicalResearch#HealthcareProfessionals

APASL Oncology 2026 Tokyo will be held in Tokyo on April 2-3, 2026 !! Abstract Submission is available until December31, 2025 form the following URL !! https://www.apasl-oncology2026tokyo.org/abs.html We are waiting for your submission !!

APASL Hepatology Webinar 9-3 Highlight of “Hepatology International ” will be held on September 26 !! With the theme of ACLF& Others, we are glad to hold a fulfilling webinar with eminent panelists, moderators and speakers !!

Please check our the latest information about APASL 2026 Istanbul !! https://www.apasl2026istanbul.org/ We are waiting for your participation !!

We plan to hold TWO STCs in January in Delhi, India. We are so excited to welcome you to the fulfilling conferences !!

Please check out the details of APASL STC 2026 New Delhi !! We look forward to your participation !!

APASL STC 2025 Moscow is changing its format to online !! We look forward to your active participation !!